- Ozturk N, Erdal E, Mumcuoglu M, Akcali KC, Yalcin O, Senturk S, Arslan-Ergul
A, Gur B, Yulug I, Cetin-Atalay R, Yakicier C, Yagci T, Tez M, Ozturk M.
Reprogramming of replicative senescence in hepatocellular carcinoma-derived
cells. Proceedings of National Academy of Sciences USA 103:2178-2183, 2006.
- Benhaj K, Akcali KC, Ozturk M. Redundant expression of canonical
Wnt ligands in human breast cancer cell lines.Oncol Reports15:701-707, 2006.
- Erdal E, Ozturk N, Cagatay T, Eksioglu-Demiralp E, Ozturk M. Lithium-mediated
downregulation of PKB/Akt and cyclin E with growth inhibition in hepatocellular
carcinoma cells. International Journal of Cancer 115:903-910, 2005.
- Voeltzel T, Morel AP, Rostan MC, Ji J, Chiodino C, Ponchel F, Vigouroux
J, de Fromentel CC, Soussi T, Ozturk M. A new set of monoclonal antibodies
directed to proline-rich and central regions of p53. Hybridomas & Hybridomics
23:287-292, 2004.
- Ugur H, Sayan AE, Ozdamar SO, Kanpolat Y, Ozturk M. Expression
of TAP73 and DeltaNP73 in malignant gliomas. Oncology Reports 11:1337-1341,
2004.
- Irmak MB, Ince G., Ozturk M and Cetin-Atalay R. Acquired tolerance
of hepatocellular carcinoma cells to selenium deficiency: a selective survival
mechanism? Cancer Research 63: 6707-6715, 2003.
- Atalay A, Crook T, Ozturk M and Yulug UG. Identification of genes
induced by BRCA1 in breast cancer cells. Biochemical and Biophysical Research
Communications 299:839-846, 2002.
- Cagatay T and Ozturk M. p53 mutation as a source of aberrant
β-catenin
accumulatıon in cancer cells. Oncogene 21:7971-7980, 2002.
- Yildiz E, Oztan A, Sar F, Pınarbaşı E, Cetin-Atalay R, Akkız H and
Ozturk M. Molecular characterization of a full genome Turkish Hepatitis
C virus 1b isolate (HCV-TR1): a predominant viral form in Turkey. Virus Genes
25: 169-177, 2002.
|
